Evenity 210 MG dose-2 syringes 1.17ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU1M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,428
Award facts
- Contract value 100% obligated
- $19,428.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19.43K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 12, 2026, for the supply of Evenity 210 mg dose in 2-syringes 1.17ml formulations. This is a firm fixed-price, non-set-aside contract with a completion deadline of February 3, 2026, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99M through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen demonstrates significant capability in federal pharmaceutical procurement through its extensive portfolio of delivery orders with the Defense Logistics Agency, covering medications across multiple therapeutic domains including specialty treatments, vaccines, and medical supplies. The company's competitively awarded contract history and substantial IDC with DLA reflect its critical role in supplying essential pharmaceutical commodities to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order represents routine pharmaceutical procurement supporting the federal government's medical supply requirements for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQU1M?
SPE2DR26FQU1M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FQU1M worth?
The government has obligated $19,428 on SPE2DR26FQU1M.
Is contract SPE2DR26FQU1M an order under another contract?
Yes. SPE2DR26FQU1M is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU1M competed?
The extent of competition for SPE2DR26FQU1M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award